Lung Cancers Completed Phase 1 Trials for Bevacizumab (DB00112)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00734890Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or LymphomaTreatment
NCT00533585BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)Treatment
NCT01069328Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)Basic Science